EarningsQ2 2024 Earnings Report

Cardiff Oncology (XE7C) Q2 2024 Earnings Report

3 Followers

DE:XE7C Q2 2024 EPS Results

Actual EPS-€0.23

Consensus EPS-€0.22

Beat/MissMissed by -€0.01

One Year Ago EPS-€0.22

Actual Revenue€145.46K

Expected Revenue€52.65K

Beat/MissBeat by +€92.81K

YoY Revenue Growth+50.93%

QuarterQ2 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

DE:XE7C Upcoming Earnings

Cardiff Oncology's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

DE:XE7C Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.12 / -	-0.152	―
Aug 11, 2026	2026 (Q2)	-0.11 / -0.12	-0.187	33.33% (+0.06)
May 14, 2026	2026 (Q1)	-0.12 / -0.16	-0.178	10.00% (+0.02)
Feb 24, 2026	2025 (Q4)	-0.17 / -0.10	-0.196	50.00% (+0.10)
Nov 06, 2025	2025 (Q3)	-0.18 / -0.15	-0.223	32.00% (+0.07)
Jul 29, 2025	2025 (Q2)	-0.17 / -0.19	-0.232	19.23% (+0.04)
May 08, 2025	2025 (Q1)	-0.17 / -0.18	-0.196	9.09% (+0.02)
Feb 27, 2025	2024 (Q4)	-0.22 / -0.20	-0.187	-4.76% (>-0.01)
Nov 07, 2024	2024 (Q3)	-0.24 / -0.22	-0.196	-13.64% (-0.03)
Aug 08, 2024	2024 (Q2)	-0.22 / -0.23	-0.223	-4.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed